FindTrial
Sign In

Prevalence of pulmonary embolism in acute exacerbation of COPD patients

To determine the prevalence and predictors of pulmonary embolism in acute exacerbation of COPD patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/11/022028
Enrollment
80
Registered
2019-11-18
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J441- Chronic obstructive pulmonary disease with (acute) exacerbation

Interventions

None listed

Sponsors

nil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All hospitalized patients with acute exacerbation of COPD presenting to Emergency department of AIIMS, Bhubaneswar those who are willing to participate in the study

Exclusion criteria

Exclusion criteria: Exclusion criteria : 1. Previous history of thromboembolic disease 2. Hypersensitivity to intravenous contrast material 3. Chronic kidney disease 4. Pneumothorax 5. Pneumonia 6. Congestive heart failure 7. Receiving anticoagulant treatment 8. Requiring invasive mechanical ventilation 9. Requiring non-invasive mechanical ventilation for more than 24hours.

Design outcomes

Primary

MeasureTime frame
To know the prevalence of pulmonary embolism in patients with acute exacerbation of COPDTimepoint: 1st december 2021—

Secondary

MeasureTime frame
factors associated with development of pulmonary embolism in patients with acute exacerbation of COPDTimepoint: 2years—

Countries

India

Contacts

Public ContactDR SADANANDA BARIK

ALL INDIA INSTITUTE OF MEDICAL SCIENCES, BHUBANESWAR

tem_sadananda@aiimsbhubaneswar.edu.in7682959066

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026